Therapeutic Specialties Archives | Page 8 of 27 | Certara

Poster

Development of Paclitaxel PBPK Model to Predict Tumour Concentration in Cancer Patients

CertaraJune 24, 2019

Poster

Mechanistic models of cancer Mechanistic models cancer-immune cycle and immunotherapies

CertaraJune 24, 2019

Poster

Integration of a Tumour Growth Inhibition Model within a Mouse Physiologically-Based Pharmacokinetic Model

CertaraJune 24, 2019

White Paper

Optimize Immuno-oncology Drug Discovery and Development Using QSP

A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…

CertaraJune 19, 2019

On-Demand Webinar

Advanced Analytics Using RWD Mitigates Risks in AD Drug Development & Reimbursement

This webinar explained how advanced analytics using real-world data can mitigate challenges in Alzheimer’s disease…

CertaraMay 13, 2019

Poster

Population Pharmacokinetic Analysis of DS-8201a, A HER2-Targeting Antibody-Drug Conjugate, in Patients with HER2-Positive Breast Cancer or Other Solid Tumors

CertaraMay 2, 2019

Poster

Simulating the Impact of the Interplay Between CYP2C19 Polymorphisms and Ethnicity on Response to Clopidogrel, Using PBPK-PD Models

CertaraApril 22, 2019

Poster

Development of a Physiologically-Based Pharmacokinetic Model for Topical Lidocaine in Order to Predict Systemic Absorption in Healthy Volunteers, Geriatrics, and Pediatrics

CertaraApril 22, 2019

Poster

Exposure-Response Analyses to Support Dose Justification of DS-8201A, A HER2-Targeting Antibody-Drug Conjugate, in HER2-Positive Breast Cancer Patients

CertaraApril 22, 2019

Poster

Relationship of Ivosidenib Plasma Concentration to Heart Rate-Corrected QT Interval in Patients with IDH1-Mutant Advanced Hematologic Malignancies

CertaraApril 22, 2019

© 2025 Certara. All Rights Reserved. | Privacy policy